Research Articles
Liquid Gold: How Cell-Free DNA is Revolutionizing Cancer Detection and Care
Exploring how cell-free DNA is transforming cancer diagnostics and therapeutic monitoring through liquid biopsies.
The Hidden Battlefield: How Ultra-Sensitive MRD Testing is Revolutionizing Multiple Myeloma Treatment
Exploring how next-generation sequencing and flow cytometry are transforming minimal residual disease detection in multiple myeloma treatment.
Dollars and Biomarkers: The Economic Revolution Reshaping Cancer Drug Development
Exploring how biomarkers are transforming the economics of oncology drug development through precision medicine approaches.
The Time Benders: How Science Conquered a Childhood Aging Disease
The scientific breakthrough behind Zokinvy (lonafarnib), the first FDA-approved drug for Hutchinson-Gilford Progeria Syndrome (HGPS), a rare genetic aging disease.
Nature's Molecular Armor: How Plant-Derived Cyclotides Are Revolutionizing Cancer Therapy
Discover how plant-derived cyclotides are being engineered to target Hdm2/HdmX and restore p53 function in cancer therapy.
Unlocking Cancer's Code: Why JJCO's New "Cancer Genetics Report" Signals a Revolution in Oncology
Exploring the groundbreaking 'Cancer Genetics Report' section in JJCO and its impact on personalized cancer medicine in the post-sequencing age.
The Fungal Gold Rush: How Mold in Plants is Revolutionizing Cancer Treatment
Discover how endophytic fungi like Aspergillus fumigatus and Alternaria tenuissima are revolutionizing paclitaxel production for cancer treatment through sustainable biotech methods.
The Blue-Green Treasure: Unlocking Oscillatoria limosa's Healing Powers
Discover how Oscillatoria limosa from Pakistan's Jamshoro district shows remarkable antioxidant, antimicrobial, and anticancer properties.
The Hidden Pharmacy in Poplar Roots: Actinocorallia populi's Genomic Treasure Trove
Discover the pharmaceutical potential of Actinocorallia populi A251T, a rare actinomycete with extraordinary capacity to produce novel therapeutic compounds.
The Invisible Architect: How E-cadherin's Disappearance Rewrites Breast Cancer's Playbook
Exploring how E-cadherin loss in breast cancer drives invasion through methylation, mutations, and cadherin switching, with diagnostic and therapeutic implications.